boundlessbio.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $252.05MM
Boundless Bio, founded in 2018, is a biopharmaceutical company that develops novel cancer therapeutics seeking to understand and treat intractable cancers. Boundless Bio aims to interrogate extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers. Boundless Bio is headquartered in La Jolla, California.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/16/2023 | Series C | $100MM | $xx.xx | $273.76MM | Bayer, RA Capital Management, Sectoral Asset Management, Piper Heartland, Healthcare Capital | |
Price per Share
$xx.xx
Shares Outstanding
142,857,138
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Bayer, RA Capital Management, Sectoral Asset Management, Piper Heartland, Healthcare Capital
|
||||||
04/28/2021 | Series B | $105.59MM | $xx.xx | $262.52MM | RA Capital Management, Nextech, Fidelity, Redmile Group, Wellington Management, Surveyor Capital, PFM Health Sciences, Logos Capital, ARCH Venture Partners, City Hill Ventures, Vertex Ventures HC, GT Healthcare Capital Partners, Boxer Capital, Alexandria Venture Investments | |
Price per Share
$xx.xx
Shares Outstanding
78,211,116
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
RA Capital Management, Nextech, Fidelity, Redmile Group, Wellington Management, Surveyor Capital, PFM Health Sciences, Logos Capital, ARCH Venture Partners, City Hill Ventures, Vertex Ventures HC, GT Healthcare Capital Partners, Boxer Capital, Alexandria Venture Investments
|
||||||
09/19/2019 | Series A | $46.47MM | $xx.xx | $103.26MM | ARCH Venture Partners, City Hill Ventures, Vertex Ventures, GT Healthcare Capital Partners, Boxer Capital, Alexandria Venture Investments | |
Price per Share
$xx.xx
Shares Outstanding
66,378,590
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
ARCH Venture Partners, City Hill Ventures, Vertex Ventures, GT Healthcare Capital Partners, Boxer Capital, Alexandria Venture Investments
|